YOLFTbeta
Kanabo Group PLC

Kanabo Group PLC

KNB · LSE · Healthcare / Medical Care Facilities

0.225GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.225
Open0.225
Day Range0.225 – 0.225
52-Week Range0.225 – 0.225
Volume0
Market Cap1.42M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta2.32
50-Day Avg0.0023
200-Day Avg0.0112

About

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Avihu Tamir
  • Employees20
  • HeadquartersChurchill House, London, United Kingdom, NW4 4DJ, UK
  • Websitehttps://www.kanabogroup.com

Leadership

  • Mr. Avihu TamirCEO, Executive Director & Secretary · b. 1981
  • Mr. David SackCo-founder
  • Mr. Assaf VardimonChief Financial Officer · b. 1978
  • Mr. Suleman SacranieChief Technology Officer

Financials

Income Statement

Currency: GBP2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Total Revenue-0-60.00K73.00K603.00K895.00K
Growth (%)----+21.67%+726.03%+48.42%
Cost of Revenue---26.00K66.00K404.00K761.00K
Gross Profit---34.00K7.00K199.00K134.00K
Gross Margin---56.67%9.59%33.00%14.97%
Operating Expense---190.00K2.81M5.59M7.93M
Operating Income-191.00K-161.00K-365.00K-156.00K-2.80M-5.39M-7.79M
Operating Margin----260.00%-3841.10%-894.20%-870.73%
EBITDA-191.00K-161.00K-365.00K-156.00K-4.54M-5.75M-6.47M
EBITDA Margin----260.00%-6224.66%-954.39%-723.02%
Net Income-190.00K-157.00K-361.00K-106.00K-8.07M-8.00M-7.99M
Net Income Margin----176.67%-11052.05%-1326.20%-892.40%
R&D---174.00K258.00K597.00K312.00K
R&D as % of Total Revenue---290.00%353.42%99.00%34.86%
Interest Expense00028.00K4.00K56.00K72.00K
Interest Expense % of Total Revenue---46.67%5.48%9.29%8.04%

Balance Sheet

Currency: GBP2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Total Assets1.09M1.05M710.00K792.00K5.60M14.45M8.35M
Total Liabilities58.00K17.00K36.00K54.00K415.00K2.01M849.00K
Total Equity1.03M1.04M674.00K738.00K5.18M12.45M7.51M
Cash1.08M1.04M597.00K359.00K4.48M3.20M1.68M
Total Debt---425.00K6.00K707.00K272.00K
Net Debt-1.08M-1.04M-597.00K66.00K-4.47M-2.50M-1.41M

Cash Flow

Currency: GBP2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Operating Cash Flow-91.00K-211.00K-346.00K-100.00K-2.08M-3.78M-2.52M
Investing Cash Flow9232.00K2.00K-300.00K-1.01M77.00K-1.70M
Financing Cash Flow1.17M168.00K-100.00K162.00K7.24M2.40M2.56M
Capital Expenditure00035.00K35.00K154.00K533.00K
Free Cash Flow-91.00K-211.00K-346.00K-100.00K-2.11M-3.93M-3.05M
FCF to OCF100.00%100.00%100.00%100.00%101.68%104.08%121.15%

Earnings

Report DateSep 21, 2017Apr 18, 2018Sep 5, 2018Apr 30, 2019Jul 25, 2019Mar 11, 2020Jul 30, 2020Jun 2, 2021Oct 22, 2021Jun 13, 2022Sep 30, 2022May 2, 2023Sep 30, 2024
EPS Estimate0.000.000.000.000.000.000.000.00-0.00--0.00
EPS Actual-0.020.000.000.00-0.01-0.010.000.00-0.01-0.01-0.01-0.010.00
Surprise-------------
Timing----------Pre-marketPre-market-

Key Statistics & Ratios

Market Cap1.42M
Enterprise Value84.96K
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.25
Price / Book0.24
EPS-0.01
Book Value0.009
Revenue (TTM)1.14M
Gross Profit (TTM)90.00K
EBITDA-2.70M
Profit Margin0.00%
Operating Margin-244.38%
Return on Equity-83.19%
Return on Assets-20.89%
Shares Outstanding632.43M
Shares Float379.60M
Beta2.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%